The Current Ratio as of December 2025 (TTM) for Hepion Pharmaceuticals, Inc. (HEPA) is 7.60

According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.60. This represents a change of 88.06% compared to the average of 4.04 of the last 4 quarters.

Hepion Pharmaceuticals, Inc. (HEPA) Historical Current Ratio (quarterly & annually)

How has HEPA Current Ratio performed in the past?

The mean historical Current Ratio of Hepion Pharmaceuticals, Inc. over the last ten years is 5.03. The current 7.60 Current Ratio has changed 14.99% with respect to the historical average. Over the past ten years (40 quarters), HEPA's Current Ratio was at its highest in in the March 2021 quarter at 41.06. The Current Ratio was at its lowest in in the December 2024 quarter at 0.51.

Hepion Pharmaceuticals, Inc. (HEPA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hepion Pharmaceuticals, Inc. (HEPA) Average Current Ratio

How has HEPA Current Ratio performed in the past?

The current Current Ratio of Hepion Pharmaceuticals, Inc. (HEPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hepion Pharmaceuticals, Inc. (HEPA) Current Ratio vs. Peers

How is HEPA’s Current Ratio compared to its peers?

Hepion Pharmaceuticals, Inc.’s Current Ratio is greater than CDT Equity Inc. (1.66), greater than ZyVersa Therapeutics, Inc. (0.08), greater than SCWorx Corp. (1.13), greater than Longevity Health Holdings Inc. (0.42), greater than NewGenIvf Group Limited (1.17), greater than Envoy Medical, Inc. (0.64), greater than Lixte Biotechnology Holdings, Inc. (1.84), greater than Enveric Biosciences, Inc. (2.43), less than Surrozen, Inc. (16.41), greater than Petros Pharmaceuticals, Inc. (2.22),

Build a custom stock screener for Hepion Pharmaceuticals, Inc. (HEPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hepion Pharmaceuticals, Inc. (HEPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.